MariMed (OTCMKTS:MRMD – Get Free Report) and Clever Leaves (NASDAQ:CLVRW – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.
Analyst Ratings
This is a breakdown of current recommendations for MariMed and Clever Leaves, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
MariMed | 0 | 0 | 0 | 1 | 4.00 |
Clever Leaves | 0 | 0 | 0 | 0 | 0.00 |
Given Clever Leaves’ higher possible upside, analysts clearly believe Clever Leaves is more favorable than MariMed.
Profitability
Net Margins | Return on Equity | Return on Assets | |
MariMed | -10.97% | -2.75% | -1.06% |
Clever Leaves | N/A | N/A | N/A |
Valuation & Earnings
This table compares MariMed and Clever Leaves”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
MariMed | $148.60 million | 0.32 | -$16.03 million | ($0.03) | -4.17 |
Clever Leaves | $17.42 million | N/A | N/A | N/A | N/A |
Clever Leaves has lower revenue, but higher earnings than MariMed.
Insider and Institutional Ownership
0.2% of MariMed shares are held by institutional investors. 19.0% of MariMed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
MariMed beats Clever Leaves on 5 of the 9 factors compared between the two stocks.
About MariMed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
About Clever Leaves
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.